Financhill
Back

Novo Nordisk AS 10K Form

Sell
44

NONOF
Novo Nordisk AS

Last Price:
$87.40
Seasonality Move:
4.97%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NONOF News And Ratings

See the #1 stock for the next 7 days that we like better than NONOF

NONOF Financial Statistics

Sales & Book Value

Annual Sales: $42.1B
Cash Flow: $-786.4M
Price / Cash Flow: 38.59
Annual Sales: $4.51
Price / Book: 19.38

Profitability

EPS (TTM): 3.28330
Net Income (TTM): $14.7B
Gross Margin: $35.7B
Return on Equity: 86.85%
Return on Assets: 27.39%

Novo Nordisk AS Earnings Forecast

Key Novo Nordisk AS Financial Ratios

  • The Gross Profit Margin over the past 41 years for NONOF is 84.67%.
  • The Selling, General & Administrative Expenses for NONOF have been equal to 23.20% of Gross Profit Margin.
  • The Research & Development expenses have been 16.55% of Revenue.
  • The Interest Expense is 1.62% of Operating Income.
  • The Net Earning history of NONOF is 34.78% of Total Revenues.
  • Per Share Earnings over the last 41 years have been positive in 36 years.

Novo Nordisk AS Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: NONOF
Website: novonordisk.com

Debt

Debt-to-Equity Ratio: 0.67
Current Ratio: 0.74
Quick Ratio: 0.52

Price-to-Earnings

Trailing P/E Ratio: 26.62
Forward P/E Ratio: 0

NONOF Technical Analysis vs Fundamental Analysis

Sell
44
Novo Nordisk AS (NONOF) is a Sell

Is Novo Nordisk AS a Buy or a Sell?

  • Novo Nordisk AS stock is rated a Sell
    The current Novo Nordisk AS [NONOF] share price is $87.40. The Score for NONOF is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.